Summary:
Click image to enlargeThis study seeks to evaluate the safety and effectiveness of an investigational medication to reduce the symptoms of Crohn’s Disease (CD.)
Qualified Participants Must:
• Be ages 16 to 80 years old
•
For participants less than 18 years of age, the participant must weigh at least 40 kg and have parental consent
• Have a diagnosis of CD with an onset of symptoms for a minimum of 3 months prior to screening
• Have moderately to severely active Crohn's Disease
Qualified Participants May Receive:
Qualified participants may receive all study-related care and study medication at no cost. Compensation may be given for time and travel.